AlphaFold 3和AI筛选平台加速新药研发进程。
The release of AlphaFold 3 pushes AI applications in drug discovery to new heights. Combined with AI-driven virtual screening platforms, drug development cycles have shortened from the traditional 10 years to 2-3 years. Multiple pharmaceutical companies like Pfizer and Roche have adopted AI-assisted design of preclinical drug candidates. In the first half of 2026, the number of AI-discovered compounds entering clinical trials hit an all-time high.